In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Type 1 selected

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Showing 11 to 13 of 13

TitleConsultationTypeConsultation end date
Teclistamab for treating relapsed or refractory multiple myeloma after 1 or more treatments ID6628Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Mezigdomide with dexamethasone and carfilzomib for treating relapsed or refractory multiple myeloma after at least 1 line of treatment ID6513Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Renal sympathetic denervation for resistant hypertensionDraft scope consultationHealthTech guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All